Navidea Biopharmaceuticals

YTD

ALL

Why Robinhood?

You can watch NAVB and buy or sell other stocks, ETFs, and their options commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.

CEO

Michael S. Rosol, PhD

CEOMichael S. Rosol, PhD

Employees

—

Employees—

Headquarters

Columbus, Ohio

HeadquartersColumbus, Ohio

Founded

1983

Founded1983

Employees

—

Employees—

NAVB Key Statistics

Market cap

10.00K

Market cap10.00K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

98.96K

Average volume98.96K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.05

52 Week high$0.05

52 Week low

—

52 Week low—

Stock Snapshot

The current Navidea Biopharmaceuticals(NAVB) stock price is $1.61, with a market capitalization of 10K.

On 2025-12-20, Navidea Biopharmaceuticals(NAVB) stock opened at —, reached a high of —, and a low of —.

The Navidea Biopharmaceuticals(NAVB)'s current trading volume is 0, compared to an average daily volume of 98.96K.